Jean Villard

9PUBLICATIONS
73CO-AUTHORS
Nanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 23, 2026
Normalization of nCounter Gene Expression Data Alters Molecular Diagnostics in Kidney Transplantation.

|Jun 27, 2025
Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer.

Margaux Saillard, Mara Cenerenti, Patrick Reichenbach

|Jul 24, 2024
NK- and T-cell repertoire is established early after allogeneic HSCT and is imprinted by CMV reactivation.

Antonia Schäfer, Zuleika Calderin Sollet, Marie-Priscille Hervé

|Jul 23, 2024
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors.

Rémi Vernet, Eugenio Fernandez, Denis Migliorini

|May 11, 2024
Multi-centre analytical performance verification of an IVD assay to quantify donor-derived cell-free DNA in solid organ transplant recipients.

Sílvia Casas, Narin S Tangprasertchai, Katerina Oikonomaki

|Jul 18, 2023
HLA variants and TCR diversity against SARS-CoV-2 in the pre-COVID-19 era.

Stéphane Buhler, Zuleika Calderin Sollet, Florence Bettens

Pageof 2

Frequent Collaborators

3 joint publications

Stéphane Buhler

2 joint publications

Klemens Budde

2 joint publications

Yves Chalandon

2 joint publications

Valentin Goutaudier